Troy Wilson

Troy E.
Wilson was the founder of Ambrx, Inc. founded in 2003, serving as Chief Business Officer.
Dr. Wilson was the founder of Intellikine LLC founded in 2007, serving as President, Chief Executive Officer & Director from 2007 to 2012.
Dr. Wilson was the founder of Avidity Biosciences, Inc. founded in 2012, serving as Non-Executive Chairman from 2021 to 2026.
Dr. Wilson was the founder of Araxes Pharma LLC founded in 2012, serving as President, CEO, Director & Managing Member from 2012 to 2019.
Dr. Wilson was the founder of Kura Oncology, Inc. founded in 2014, serving as Chairman, President, Chief Executive Officer & CFO from 2022 to 2026.
Dr. Wilson is also the founder of Wildcat Discovery Technologies, Inc...
Dr. Wilson is Executive Chairman at Abintus Bio, Inc. since 2020.
Dr. Wilson is Independent Director at Puma Biotechnology, Inc. since 2013.
Dr. Wilson is Director at Atrium Therapeutics, Inc. starting 2026.
Dr. Wilson is Director at Cipher Genetics, Inc. Dr. Wilson is Director at Cartography Biosciences, Inc. Dr. Wilson is Director at Montara Therapeutics, Inc. Dr. Wilson was Chairman, President & Chief Executive Officer at Zeta Acquisition Corp.
III.
Dr. Wilson was Chief Executive Officer at Takeda Pharmaceuticals U.S.A., Inc. Dr. Wilson was Executive Chairman at Wellspring Biosciences LLC from 2019 to 2023.
Dr. Wilson was Director at ZP Opco, Inc. Dr. Wilson was Independent Director at Zosano Pharma Corp.
from 2014 to 2019.
Dr. Wilson was Founding Partner at Presidio Partners.
Dr. Wilson was Vice President-Business Development at Novartis Institute for Functional Genomics, Inc. Dr. Wilson completed graduate education at New York University.
Dr. Wilson completed undergraduate and doctorate education at the University of California, Berkeley.